Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
The EMBO Journal|June 25, 2004
Oxygen-induced maturation of SOD1: a key role for disulfide formation by the copper chaperone CCSYoshiaki Furukawa, Andrew S Torres, Thomas V O'Halloran
Medical Hypotheses|July 30, 2020
Electrical stimulation of whole blood for growth factor release and potential clinical implicationsAllen L Garner, Andrew S Torres, Steve Klopman, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 6, 2004
Oxygen and the copper chaperone CCS regulate posttranslational activation of Cu,Zn superoxide dismutaseNina M Brown, Andrew S Torres, Peter E Doan, et al.
Journal of Medical Imaging (Bellingham, Wash.)|February 4, 2016
Complementary contrast media for metal artifact reduction in dual-energy computed tomographyJack W Lambert, Peter M Edic, Paul F FitzGerald, et al.
Chemical Communications (Cambridge, England)|October 27, 2010
Synthesis, characterization, and computed tomography imaging of a tantalum oxide nanoparticle imaging agentPeter J Bonitatibus, Andrew S Torres, Gregory D Goddard, et al.
EURASIP Journal on Bioinformatics & Systems Biology|March 5, 2008
MicroRNA target detection and analysis for genes related to breast cancer using MDLcompressScott C Evans, Antonis Kourtidis, T Stephen Markham, et al.
Contrast Media & Molecular Imaging|February 20, 2016
In vivo comparison of tantalum, tungsten, and bismuth enteric contrast agents to complement intravenous iodine for double-contrast dual-energy CT of the bowelSamira Rathnayake, John Mongan, Andrew S Torres, et al.
ACS Nano|July 10, 2012
Preclinical assessment of a zwitterionic tantalum oxide nanoparticle X-ray contrast agentPeter J Bonitatibus, Andrew S Torres, Binil Kandapallil, et al.
Investigative Radiology|July 28, 2012
Biological performance of a size-fractionated core-shell tantalum oxide nanoparticle x-ray contrast agentAndrew S Torres, Peter J Bonitatibus, Robert E Colborn, et al.
Pageof 2